2methoxy4[44methylpiperazin1ylpiperidin1yl]phenylamine
New Products From This Supplier
The 2methoxy4[44methylpiperazin1ylpiperidin1yl]phenylamine that we bring you stands out of all others on counts of quality, reliability and pricing. Our 2methoxy4[44methylpiperazin1ylpiperidin1yl]phenylamine quickly gained popularity along with the added range of products including api,customs synthesis product,selumetinib,ibuprofen piconol,cabozantinib. As a leading Manufacturer and Importer of Piperidine, we deliver products as per international quality standards in 60 per KGs price range. To ensure utmost customer satisfaction, CHEMPROSPECT PHARMTECH CO., LTD offers FOB, FCA freight options to deliver the order within 10 - 15 Working Days. Our advanced corporate venture in Wuhan, Hubei, Wuhan, holds annual production capacity of 200 KGs. We are open for online orders that estimate around 1 KGs and the order is delivered from Wuhan port. To keep the payments flexible different currencies are accepted including CNY,USD via T/T, Credit Card.
Business Nature
Manufacturer
No. Employees
5 - 10 People
Year Established
2014
Annual Turnover
US$50 Million - US$100 Million
Country/Region
Wuhan, China
Main Products
Api, Customs Synthesis Product, Selumetinib, Ibuprofen Piconol, Cabozantinib...
Legal Status
Have Own Export License
Payment Terms
Bank wire (T/T), Letter of Credit (L/C), MoneyGram, Credit Card (CC), PayPal, Western Union (WU), Cash, Escrow
CHEMPROSPECT PHARMTECH CO., LTD is one of the leading Manufacturer supplying Chemicals, Dyes & Solvents and many more China API, customs synthesis product, Selumetinib, Ibuprofen piconol, CABOZANTINIB products. The headoffice of CHEMPROSPECT PHARMTECH CO., LTD is sited in A2106, Pengcheng International, Luoyu Road Wuhan Hubei *** China. CHEMPROSPECT PHARMTECH CO., LTD is a identified venture in China that is trading in large scale market. CHEMPROSPECT PHARMTECH CO., LTD Information Name: Catherine
Address: A2106, Pengcheng International, Luoyu Road Wuhan Hubei ***
Country: China
Main Products: API, customs synthesis product, Selumetinib, Ibuprofen piconol, CABOZANTINIB
Year Established: 2014
Export Focus: Australia, United States
Estimated Employees: 11 - 50 People
Registered Capital: US$5 Million
Ownership Status: Private Limited
Export Percentage: 51% - 60%
Factory Size: 3, 000-5, 000 square meters
Production Lines: 10
Research Team Size: 51 - 100 People
Contract Services: OEM Service Offered
